BARD ASSOCIATES INC - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARD ASSOCIATES INC ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$596,120
-23.5%
48,4650.0%0.25%
-18.2%
Q2 2023$778,833
-7.7%
48,4650.0%0.30%
-13.5%
Q1 2023$843,776
+88.4%
48,4650.0%0.35%
+80.8%
Q4 2022$447,817
+7.4%
48,4650.0%0.19%
+2.7%
Q3 2022$417,000
+5.6%
48,4650.0%0.19%
+11.2%
Q2 2022$395,000
-31.9%
48,465
+1.6%
0.17%
-17.6%
Q1 2022$580,000
-64.4%
47,7000.0%0.20%
-61.7%
Q4 2021$1,627,000
-35.3%
47,700
-8.4%
0.54%
-37.0%
Q3 2021$2,513,000
+6.8%
52,1000.0%0.85%
+10.3%
Q2 2021$2,353,000
-45.9%
52,100
-42.2%
0.77%
-51.0%
Q1 2021$4,350,000
-82.3%
90,200
-80.3%
1.57%
-19.2%
Q4 2020$24,630,000
+45.4%
457,500
-0.3%
1.94%
+8.2%
Q3 2020$16,935,000
+18.8%
459,000
-0.2%
1.80%
+13.5%
Q2 2020$14,250,000
+461.0%
460,000
+400.0%
1.58%
-15.3%
Q1 2020$2,540,000
-18.5%
92,000
-13.6%
1.87%
+18.0%
Q4 2019$3,115,000
+44.8%
106,500
-5.3%
1.58%
+44.9%
Q3 2019$2,151,000
-13.5%
112,500
-0.7%
1.09%
-11.8%
Q2 2019$2,486,000
+2.1%
113,300
-4.8%
1.24%
+1.1%
Q1 2019$2,435,000
+44.6%
119,000
-10.9%
1.23%
+26.1%
Q4 2018$1,684,000
-88.8%
133,550
-86.4%
0.97%
-30.1%
Q3 2018$15,080,000
+16.4%
982,465
-0.6%
1.39%
+15.7%
Q2 2018$12,955,000
+544.2%
988,165
+300.9%
1.20%
+20.0%
Q1 2018$2,011,000
-10.5%
246,483
-2.8%
1.00%
-7.0%
Q4 2017$2,246,000
-21.4%
253,483
-1.2%
1.08%
-19.0%
Q3 2017$2,856,000
+20.2%
256,623
-3.2%
1.33%
+23.4%
Q2 2017$2,376,000
-77.4%
265,223
-80.1%
1.08%
+10.5%
Q1 2017$10,505,000
+324.3%
1,331,615
+360.9%
0.98%
-15.1%
Q4 2016$2,476,000
+2.8%
288,923
-1.4%
1.15%
-2.1%
Q3 2016$2,408,000
+1.5%
292,923
-0.7%
1.18%
-6.4%
Q2 2016$2,372,000
+10.2%
295,003
-7.6%
1.26%
+1.3%
Q1 2016$2,153,000
-15.6%
319,423
-1.4%
1.24%
-17.6%
Q4 2015$2,550,000
+0.7%
324,023
-26.7%
1.50%
+3.2%
Q3 2015$2,532,000
+1.4%
441,950
-4.2%
1.46%
+17.8%
Q2 2015$2,496,000
+10.2%
461,450
-4.8%
1.24%
+14.0%
Q1 2015$2,264,000
+10.5%
484,900
-1.3%
1.09%
+13.5%
Q4 2014$2,048,000
-20.1%
491,100
-0.2%
0.96%
-20.2%
Q3 2014$2,564,000
+54.2%
492,100
-1.8%
1.20%
+82.4%
Q2 2014$1,663,000
-6.3%
500,900
-2.0%
0.66%
-12.3%
Q1 2014$1,774,000
-7.1%
511,100
-2.1%
0.75%
-5.5%
Q4 2013$1,909,000
+19.7%
522,000
-1.8%
0.79%
+12.5%
Q3 2013$1,595,000
-25.5%
531,700
-1.1%
0.71%
-29.5%
Q2 2013$2,140,000537,7001.00%
Other shareholders
NEOGENOMICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,516,313$14,0118.43%
Greenhouse Funds LLLP 2,795,231$25,827,9342.36%
First Light Asset Management, LLC 2,682,171$24,783,2602.30%
PERKINS CAPITAL MANAGEMENT INC 197,700$1,8271.93%
Altium Capital Management LP 285,000$2,633,4001.34%
EMERALD MUTUAL FUND ADVISERS TRUST 1,654,543$15,287,9770.95%
EMERALD ADVISERS, LLC 2,101,567$19,418,4790.94%
Bullseye Asset Management LLC 105,997$9800.53%
OAK FAMILY ADVISORS, LLC 101,194$935,0330.50%
FORMULA GROWTH LTD 180,300$1,665,9720.47%
View complete list of NEOGENOMICS INC shareholders